The fast developing Next Generation Sequencing (NGS) technology created unprecedented amount of data. There is a huge need for approaches to properly use the data to guide scientific research and clinical practice. The goal of Quick Biology Inc. is to develop novel approaches to facilitate researches to manage, validate and interpret the NGS results so that novel discoveries can be timely translated into products.

For more information:
www.quickbiology.com